glp 1 data GLP-1 trends 2025: real-world data, patient outcomes & future therapies GLP-1s — Dandelion Health
Description
Diet None, just more protein
Incretin-Based Glucose-Lowering Medications and the Risk of Acute Pancreatitis and Malignancies: A Meta-Analysis Based on Cardiovascular Outcomes Trials
Wainscott D
Those kind of counterfeit operations that are being conflated with legitimate compounding are hurting the image of compounding, even though we have all sorts of standards that we have to operate under. Brunner acknowledged the FDAs concerns regarding overdosing of compounded semaglutide and tirzepatide but said that specific warning did not mention drug contamination
The potential for more robust, structured nutrition and lifestyle therapy to mitigate weight gain following GLP-1 cessation has not been studied in controlled trials
Others are oblivious to the FDAs historical handling of obesity drugs and are yet stubbornly opposed to new approvals
